Reporting guideline for priority setting of health research (REPRISE)
dc.contributor.author | Tong, A | |
dc.contributor.author | Synnot, A | |
dc.contributor.author | Crowe, S | |
dc.contributor.author | Hill, S | |
dc.contributor.author | Matus, A | |
dc.contributor.author | Scholes-Robertson, N | |
dc.contributor.author | Oliver, S | |
dc.contributor.author | Cowan, K | |
dc.contributor.author | Nasser, Mona | |
dc.contributor.author | Bhaumik, S | |
dc.contributor.author | Gutman, T | |
dc.contributor.author | Baumgart, A | |
dc.contributor.author | Craig, JC | |
dc.date.accessioned | 2021-09-28T10:42:34Z | |
dc.date.issued | 2019-12-28 | |
dc.identifier.issn | 1471-2288 | |
dc.identifier.issn | 1471-2288 | |
dc.identifier.other | 243 | |
dc.identifier.uri | http://hdl.handle.net/10026.1/17964 | |
dc.description.abstract |
Abstract Background Research priority setting with stakeholders can help direct the limited resources for health research toward priority areas of need. Ensuring transparency of the priority setting process can strengthen legitimacy and credibility for influencing the research agenda. This study aims to develop a reporting guideline for priority setting of health research. Methods We searched electronic databases and relevant websites for sources (frameworks, guidelines, or models for conducting, appraising, reporting or evaluating health research priority setting, and reviews (including systematic reviews)), and primary studies of research priority setting to July 2019. We inductively developed a list of reporting items and piloted the preliminary guideline with a diverse range of 30 priority setting studies from the records retrieved. Results From 21,556 records, we included 26 sources for the candidate REPRISE framework and 455 primary research studies. The REporting guideline for PRIority SEtting of health research (REPRISE) has 31 reporting items that cover 10 domains: context and scope, governance and team, framework for priority setting, stakeholders/participants, identification and collection of priorities, prioritization of research topics, output, evaluation and feedback, translation and implementation, and funding and conflict of interest. Each reporting item includes a descriptor and examples. Conclusions The REPRISE guideline can facilitate comprehensive reporting of studies of research priority setting. Improved transparency in research priority setting may strengthen the acceptability and implementation of the research priorities identified, so that efforts and funding are invested in generating evidence that is of importance to all stakeholders. Trial registration Not applicable. | |
dc.format.extent | 0-0 | |
dc.format.medium | Electronic | |
dc.language | en | |
dc.language.iso | en | |
dc.publisher | Springer Science and Business Media LLC | |
dc.subject | Priority-setting | |
dc.subject | Reporting | |
dc.subject | Transparency | |
dc.subject | Patient involvement | |
dc.title | Reporting guideline for priority setting of health research (REPRISE) | |
dc.type | journal-article | |
dc.type | Journal Article | |
dc.type | Research Support, Non-U.S. Gov't | |
plymouth.author-url | https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000510851300001&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=11bb513d99f797142bcfeffcc58ea008 | |
plymouth.issue | 1 | |
plymouth.volume | 19 | |
plymouth.publication-status | Published | |
plymouth.journal | BMC Medical Research Methodology | |
dc.identifier.doi | 10.1186/s12874-019-0889-3 | |
plymouth.organisational-group | /Plymouth | |
plymouth.organisational-group | /Plymouth/Admin Group - REF | |
plymouth.organisational-group | /Plymouth/Admin Group - REF/REF Admin Group - FoH | |
plymouth.organisational-group | /Plymouth/Faculty of Health | |
plymouth.organisational-group | /Plymouth/Faculty of Health/Peninsula Dental School | |
plymouth.organisational-group | /Plymouth/REF 2021 Researchers by UoA | |
plymouth.organisational-group | /Plymouth/REF 2021 Researchers by UoA/UoA03 Allied Health Professions, Dentistry, Nursing and Pharmacy | |
plymouth.organisational-group | /Plymouth/Research Groups | |
plymouth.organisational-group | /Plymouth/Research Groups/Institute of Health and Community | |
plymouth.organisational-group | /Plymouth/Research Groups/Institute of Translational and Stratified Medicine (ITSMED) | |
plymouth.organisational-group | /Plymouth/Research Groups/Institute of Translational and Stratified Medicine (ITSMED)/CCT&PS | |
plymouth.organisational-group | /Plymouth/Users by role | |
plymouth.organisational-group | /Plymouth/Users by role/Academics | |
dc.publisher.place | England | |
dcterms.dateAccepted | 2019-12-17 | |
dc.rights.embargodate | 2021-9-29 | |
dc.identifier.eissn | 1471-2288 | |
dc.rights.embargoperiod | Not known | |
rioxxterms.versionofrecord | 10.1186/s12874-019-0889-3 | |
rioxxterms.licenseref.uri | http://www.rioxx.net/licenses/all-rights-reserved | |
rioxxterms.licenseref.startdate | 2019-12-28 | |
rioxxterms.type | Journal Article/Review |